Macquarie Group LTD Applied Therapeutics Inc. Transaction History
Macquarie Group LTD
- $90.3 Billion
- Q3 2024
A detailed history of Macquarie Group LTD transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 209,341 shares of APLT stock, worth $123,511. This represents 0.0% of its overall portfolio holdings.
Number of Shares
209,341
Previous 229,153
8.65%
Holding current value
$123,511
Previous $1.07 Million
66.26%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding APLT
# of Institutions
139Shares Held
111MCall Options Held
1.68MPut Options Held
1.91M-
Janus Henderson Group PLC London, X010.5MShares$6.22 Million0.05% of portfolio
-
Morgan Stanley New York, NY9.9MShares$5.84 Million0.01% of portfolio
-
Vr Adviser, LLC New York, NY9.83MShares$5.8 Million8.65% of portfolio
-
Perceptive Advisors LLC New York, NY8.01MShares$4.72 Million1.78% of portfolio
-
Franklin Resources Inc San Mateo, CA6.8MShares$4.01 Million0.02% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $28.3M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...